Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)"

Notice Number:
NOT-DA-24-025
Release Date:

April 25, 2024

Related Announcements

  • September 3, 2021 - Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional).  See NOFO PAR-22-027.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice extends the expiration date for the following funding opportunity:

  •  PAR-22-027, Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional).

New Dates: September 10, 2024, and January 13, 2025, per NOT-DA-24-025

As part of the extension, additional application due date(s) have been added to the key dates section of the opportunity as follows:

 

Application Due Dates

Review and Award Cycles

NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
January 11, 2022January 11, 2022January 11, 2022March 2022May 2022July 2022
May 03, 2022May 03, 2022May 03, 2022July 2022October 2022December 2022
September 08, 2022September 08, 2022September 08, 2022November 2022January 2023April 2023
January 11, 2023January 11, 2023January 11, 2023March 2023May 2023July 2023
May 03, 2023May 03, 2023May 03, 2023July 2023October 2023December 2023
September 08, 2023September 08, 2023September 08, 2023November 2023January 2024April 2024
January 11, 2024January 11, 2024January 11, 2024March 2024May 2024July 2024
May 03, 2024May 03, 2024May 03, 2024July 2024October 2024December 2024
September 10, 2024September 10, 2024September 10, 2024November 2024January 2025April 2025
January 13, 2025January 13, 2025January 13, 2025March 2025May 2025July 2023

 New Expiration Date: January 14, 2025

All other aspects of the opportunity(ies) remain the same.

All other aspects of the opportunity(ies) remain the same.

Inquiries

Please direct all inquiries to:

Marsha F. Lopez, PhD, MHS
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6504
Email: [email protected]